Which Markets Offer the Most Lucrative Opportunities in the Industry?

Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.

What is the period of study of the Neurological Biomarkers Market?

Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume

Neurological Biomarkers Market Size, Share, Trends, Growth Outlook |2025-2034

Home
Healthcare
|Published Month : April, 2025
|No. of Pages : 202

Overview
Table of Contents
Segmentation
Sample Request

The Global Neurological Biomarkers Market Size is estimated at $10.6 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 11.8% to reach $28.9 Billion by 2034.

The Neurological Biomarkers Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others).

An Introduction to Neurological Biomarkers Market in 2025

The Neurological Biomarkers Market is witnessing significant growth, driven by the increasing focus on precision medicine in neurology and the need for reliable diagnostic and prognostic tools for neurological disorders. Neurological biomarkers are measurable indicators in biological fluids or tissues that reflect the presence or progression of neurological conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This market encompasses biomarker discovery, testing services, and diagnostic tools. Manufacturers are investing in research to identify novel biomarkers and develop diagnostic assays. With the growing prevalence of neurological disorders and the quest for personalized treatment strategies, the Neurological Biomarkers Market is poised for sustained expansion, contributing to advancements in the understanding and management of neurological conditions.

Neurological Biomarkers Market Competitive Landscape

The market report analyses the leading companies in the industry including Abbott, Thermo Fisher Scientific, Inc., Merck & Co., Inc., Bio-Rad Laboratories, Inc., Johnson & Johnson Services, Inc., DiaGenic ASA, Banyan Biomarkers, Inc., Quanterix, Alseres Pharmaceuticals, Inc., Rules-Based Medicine

Neurological Biomarkers Market Dynamics

Market Trend: Rise in Neurodegenerative Disease Research and Diagnostic Advancements

The most prominent trend in the Neurological Biomarkers Market is the increasing focus on neurodegenerative disease research and diagnostic advancements. With the rising prevalence of neurological disorders, including Alzheimer's and Parkinson's disease, there is a growing emphasis on identifying reliable biomarkers that can aid in early detection and disease monitoring. This trend involves the integration of advanced technologies such as proteomics and genomics to discover novel biomarkers associated with various neurological conditions. The Neurological Biomarkers Market is experiencing a surge in research activities and diagnostic innovations, driven by the imperative to address the complexities of neurological diseases and improve patient outcomes through early intervention.

Market Driver: Growing Incidence of Neurological Disorders and Demand for Personalized Medicine

A major driver propelling the Neurological Biomarkers Market is the growing incidence of neurological disorders and the increasing demand for personalized medicine approaches. The prevalence of conditions such as Alzheimer's, multiple sclerosis, and stroke is on the rise, necessitating more precise and targeted diagnostic tools. The market is driven by the recognition that neurological biomarkers play a crucial role in facilitating early diagnosis, monitoring disease progression, and enabling the development of personalized treatment strategies. As healthcare systems shift towards patient-centric care, the demand for biomarker-based diagnostics in neurological disorders is escalating, driving market growth.

Market Opportunity: Integration of Neuroimaging and Biomarker Profiling for Holistic Diagnosis

An emerging opportunity in the Neurological Biomarkers Market lies in the integration of neuroimaging and biomarker profiling for a more holistic approach to diagnosis. Market players have the potential to develop innovative solutions that combine the power of neuroimaging techniques, such as MRI and PET scans, with biomarker profiling to offer a comprehensive diagnostic assessment. This opportunity involves creating integrated platforms that provide a detailed understanding of both structural and molecular changes in the brain, enhancing diagnostic accuracy and paving the way for personalized treatment plans. The integration of neuroimaging and biomarker profiling presents a valuable opportunity for companies to contribute to the advancement of precision medicine in neurology and address the evolving needs of healthcare professionals and patients. Seizing this opportunity allows companies to position themselves at the forefront of comprehensive neurological diagnostics and treatment guidance.

Neurological Biomarkers Market Segmentation

By Type

Genomic
Proteomic
Metabolomic
Imaging
Others

By Application

Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Autism Spectrum Disorder
Others

By End-user

Hospital & Hospital Laboratories
Independent clinical diagnostic centers
Research Organizations
Others

By Region

North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Others)
Asia Pacific (China, India, Japan, South Korea, Australia, Others)
Latin America (Brazil, Argentina, Others)
Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

Neurological Biomarkers Market Companies Profiled in the Study

Abbott
Thermo Fisher Scientific, Inc.
Merck & Co., Inc.
Bio-Rad Laboratories, Inc.
Johnson & Johnson Services, Inc.
DiaGenic ASA
Banyan Biomarkers, Inc.
Quanterix
Alseres Pharmaceuticals, Inc.
Rules-Based Medicine

*List not exhaustive

Reasons to Buy the Neurological Biomarkers Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Neurological Biomarkers Market, encompassing current market size, growth trends, and forecasts till 2034.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Neurological Biomarkers Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 INTRODUCTION TO 2025 Neurological Biomarkers Markets
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 RESEARCH METHODOLOGY
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 EXECUTIVE SUMMARY
3.1 Global Neurological Biomarkers Market Size Outlook, $ Million, 2021 to 2034
3.2 Neurological Biomarkers Market Outlook by Type, $ Million, 2021 to 2034
3.3 Neurological Biomarkers Market Outlook by Product, $ Million, 2021 to 2034
3.4 Neurological Biomarkers Market Outlook by Application, $ Million, 2021 to 2034
3.5 Neurological Biomarkers Market Outlook by Key Countries, $ Million, 2021 to 2034

4 MARKET DYNAMICS
4.1 Key Driving Forces of Neurological Biomarkers Market Industry
4.2 Key Market Trends in Neurological Biomarkers Market Industry
4.3 Potential Opportunities in Neurological Biomarkers Market Industry
4.4 Key Challenges in Neurological Biomarkers Market Industry
5 MARKET FACTOR ANALYSIS
5.1 Competitive Landscape
5.1.1 Global Neurological Biomarkers Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 GROWTH OUTLOOK ACROSS SCENARIOS
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 GLOBAL Neurological Biomarkers Market OUTLOOK BY SEGMENTS
7.1 Neurological Biomarkers Market Outlook by Segments
By Type
Genomic
Proteomic
Metabolomic
Imaging
Others